Year |
Citation |
Score |
2015 |
Yue M, Hinkle KM, Davies P, Trushina E, Fiesel FC, Christenson TA, Schroeder AS, Zhang L, Bowles E, Behrouz B, Lincoln SJ, Beevers JE, Milnerwood AJ, Kurti A, McLean PJ, et al. Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice. Neurobiology of Disease. 78: 172-95. PMID 25836420 DOI: 10.1016/J.Nbd.2015.02.031 |
0.592 |
|
2012 |
Hinkle KM, Yue M, Behrouz B, Dächsel JC, Lincoln SJ, Bowles EE, Beevers JE, Dugger B, Winner B, Prots I, Kent CB, Nishioka K, Lin WL, Dickson DW, Janus CJ, et al. LRRK2 knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviors. Molecular Neurodegeneration. 7: 25. PMID 22647713 DOI: 10.1186/1750-1326-7-25 |
0.604 |
|
2012 |
Simkins TJ, Janis KL, McClure AK, Behrouz B, Pappas SS, Lehner A, Kaminski NE, Goudreau JL, Lookingland KJ, Kaplan BL. Comparison of the D2 receptor regulation and neurotoxicant susceptibility of nigrostriatal dopamine neurons in wild-type and CB1/CB2 receptor knockout mice. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 7: 533-8. PMID 22639229 DOI: 10.1007/S11481-012-9375-Y |
0.702 |
|
2012 |
Benskey M, Behrouz B, Sunryd J, Pappas SS, Baek SH, Huebner M, Lookingland KJ, Goudreau JL. Recovery of hypothalamic tuberoinfundibular dopamine neurons from acute toxicant exposure is dependent upon protein synthesis and associated with an increase in parkin and ubiquitin carboxy-terminal hydrolase-L1 expression. Neurotoxicology. 33: 321-31. PMID 22342763 DOI: 10.1016/J.Neuro.2012.02.001 |
0.786 |
|
2012 |
Benskey M, Behrouz B, Sunryd J, Pappas SS, Baek S, Huebner M, Lookingland KJ, Goudreau JL. Erratum to “Recovery of hypothalamic tuberoinfundibular dopamine neurons from acute toxicant exposure is dependent upon protein synthesis and associated with an increase in parkin and ubiquitin carboxy-terminal hydrolase-L1 expression” [Neurotoxicology 33 (2012) 321–331] Neurotoxicology. 33: 406. DOI: 10.1016/J.Neuro.2012.04.013 |
0.76 |
|
2011 |
Chartier-Harlin MC, Dachsel JC, Vilariño-Güell C, Lincoln SJ, Leprêtre F, Hulihan MM, Kachergus J, Milnerwood AJ, Tapia L, Song MS, Le Rhun E, Mutez E, Larvor L, Duflot A, Vanbesien-Mailliot C, ... ... Behrouz B, et al. Translation initiator EIF4G1 mutations in familial Parkinson disease. American Journal of Human Genetics. 89: 398-406. PMID 21907011 DOI: 10.1016/J.Ajhg.2011.08.009 |
0.449 |
|
2011 |
Vilariño-Güell C, Wider C, Ross OA, Dachsel JC, Kachergus JM, Lincoln SJ, Soto-Ortolaza AI, Cobb SA, Wilhoite GJ, Bacon JA, Behrouz B, Melrose HL, Hentati E, Puschmann A, Evans DM, et al. VPS35 mutations in Parkinson disease. American Journal of Human Genetics. 89: 162-7. PMID 21763482 DOI: 10.1016/j.ajhg.2011.06.001 |
0.488 |
|
2010 |
Behrouz B, Vilariño-Güell C, Heckman MG, Soto-Ortolaza AI, Aasly JO, Sando S, Lynch T, Craig D, Uitti RJ, Wszolek ZK, Ross OA, Farrer MJ. Mitochondrial translation initiation factor 3 polymorphism and Parkinson's disease. Neuroscience Letters. 486: 228-30. PMID 20887776 DOI: 10.1016/J.Neulet.2010.09.059 |
0.49 |
|
2010 |
Dächsel JC, Behrouz B, Yue M, Beevers JE, Melrose HL, Farrer MJ. A comparative study of Lrrk2 function in primary neuronal cultures. Parkinsonism & Related Disorders. 16: 650-5. PMID 20850369 DOI: 10.1016/J.Parkreldis.2010.08.018 |
0.622 |
|
2010 |
Melrose HL, Dächsel JC, Behrouz B, Lincoln SJ, Yue M, Hinkle KM, Kent CB, Korvatska E, Taylor JP, Witten L, Liang YQ, Beevers JE, Boules M, Dugger BN, Serna VA, et al. Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice. Neurobiology of Disease. 40: 503-17. PMID 20659558 DOI: 10.1016/J.Nbd.2010.07.010 |
0.568 |
|
2010 |
Pappas SS, Tiernan CT, Behrouz B, Jordan CL, Breedlove SM, Goudreau JL, Lookingland KJ. Neonatal androgen-dependent sex differences in lumbar spinal cord dopamine concentrations and the number of A11 diencephalospinal dopamine neurons. The Journal of Comparative Neurology. 518: 2423-36. PMID 20503420 DOI: 10.1002/Cne.22340 |
0.74 |
|
2010 |
Vilariño-Güell C, Wider C, Ross OA, Jasinska-Myga B, Kachergus J, Cobb SA, Soto-Ortolaza AI, Behrouz B, Heckman MG, Diehl NN, Testa CM, Wszolek ZK, Uitti RJ, Jankovic J, Louis ED, et al. LINGO1 and LINGO2 variants are associated with essential tremor and Parkinson disease. Neurogenetics. 11: 401-8. PMID 20369371 DOI: 10.1007/S10048-010-0241-X |
0.471 |
|
2010 |
Vilariño-Güell C, Ross OA, Wider C, Jasinska-Myga B, Cobb SA, Soto-Ortolaza AI, Kachergus JM, Keeling BH, Dachsel JC, Melrose HL, Behrouz B, Wszolek ZK, Uitti RJ, Aasly JO, Rajput A, et al. LINGO1 rs9652490 is associated with essential tremor and Parkinson disease. Parkinsonism & Related Disorders. 16: 109-11. PMID 19720553 DOI: 10.1016/J.Parkreldis.2009.08.006 |
0.473 |
|
2010 |
Soto-Ortolaza AI, Behrouz B, Wider C, Vilariño-Güell C, Heckman MG, Aasly JO, Mark Gibson J, Lynch T, Jasinska-Myga B, Krygowska-Wajs A, Opala G, Barcikowska M, Czyzewski K, Uitti RJ, Wszolek ZK, et al. Calbindin-1 association and Parkinson's disease. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 17: 208-11. PMID 19674066 DOI: 10.1111/J.1468-1331.2009.02769.X |
0.505 |
|
2008 |
Janis KL, Brennan RT, Drolet RE, Behrouz B, Kaufman SK, Lookingland KJ, Goudreau JL. Effects of sildenafil on nigrostriatal dopamine neurons in a murine model of Parkinson's disease. Journal of Alzheimer's Disease : Jad. 15: 97-107. PMID 18780970 DOI: 10.3233/Jad-2008-15108 |
0.776 |
|
2008 |
Pappas SS, Behrouz B, Janis KL, Goudreau JL, Lookingland KJ. Lack of D2 receptor mediated regulation of dopamine synthesis in A11 diencephalospinal neurons in male and female mice. Brain Research. 1214: 1-10. PMID 18462709 DOI: 10.1016/J.Brainres.2008.03.010 |
0.741 |
|
2007 |
Behrouz B, Drolet RE, Sayed ZA, Lookingland KJ, Goudreau JL. Unique responses to mitochondrial complex I inhibition in tuberoinfundibular dopamine neurons may impart resistance to toxic insult. Neuroscience. 147: 592-8. PMID 17583437 DOI: 10.1016/J.Neuroscience.2007.05.007 |
0.831 |
|
2006 |
Drolet RE, Behrouz B, Lookingland KJ, Goudreau JL. Substrate-mediated enhancement of phosphorylated tyrosine hydroxylase in nigrostriatal dopamine neurons: evidence for a role of alpha-synuclein. Journal of Neurochemistry. 96: 950-9. PMID 16412098 DOI: 10.1111/J.1471-4159.2005.03606.X |
0.777 |
|
2004 |
Drolet RE, Behrouz B, Lookingland KJ, Goudreau JL. Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration. Neurotoxicology. 25: 761-9. PMID 15288507 DOI: 10.1016/J.Neuro.2004.05.002 |
0.769 |
|
Show low-probability matches. |